Clinical Trials
3 trialsNCT04405167 2025-10-07
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
University of Pennsylvania
Phase 1 Terminated
NCT02057666 2021-04-23
TasQ003
Ipsen
Phase 3 Terminated
NCT01732549 2019-11-22
A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy
Ipsen
Phase 2 Terminated